Brief: A1M Pharma Changes CEO And Reduces Costs

Disruptive Pharma AB (publ)

12/12/2018 08:03

Dec 12 (Reuters) - A1M Pharma AB  A1M.ST :
    * CHANGES CEO AND REDUCES COSTS
    * TOBIAS LARSSON AGERVALD ON 15 JANUARY 2019 TO REPLACE
TOMAS
ERIKSSON AS CEO
    * SAVING COSTS EXPECTED TO HAVE FULL EFFECT FROM Q3 2019
    * EXPECTS ANNUAL COST BASE EX CLINICAL PROJECTS COSTS TO BE
REDUCED ABOUT 30 PERCENT COMPARED TO 2018

Source text for Eikon:  ID:nBQN7dqWR8 
Further company coverage:  A1M.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))